Joe Hechavarria

Biography

Mr. Hechavarria brings over 35 years of parenteral pharmaceutical industry experience to Lyophilization Services of New England. Just prior to joining LSNE, Mr. Hechavarria provided 3rd party consulting support to Genzyme Corporation assisting in the mitigation of FDA Consent Decree & Warning observations; Previously served as VP of Manufacturing for Adventrx Pharmaceuticals Inc., a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. Mr. Hechavarria began his career at New England Nuclear Corporation where he was responsible for Quality Assurance for the radiopharmaceutical business and, later, following a succession of acquisitions by E.I. duPont de Nemours & Co., DuPont Merck Pharmaceutical Company and Bristol-Myers Squibb, served as Director of Manufacturing Technology & Development for Bristol Myers Squibb Medical Imaging, providing manufacturing leadership to several successful international product launches while overseeing contract manufacturing, Technical Support and Supply Chain logistics. Mr. Hechavarria holds a B.S. in chemical technology from the University of Lowell, an A.S. in Nuclear Engineering Technology from the Wentworth Institute, and has completed post graduate training in parenteral therapeutics agents at the University of Tennessee College of Pharmacy.

Research Interest

 PHARMACY